Complement activation in experimental and human temporal lobe epilepsy

被引:175
作者
Aronica, E.
Boer, K.
van Vliet, E. A.
Redeker, S.
Baayen, J. C.
Spliet, W. G. M.
van Rijen, P. C.
Troost, D.
da Silva, F. H. Lopes
Wadman, W. J.
Gorter, J. A.
机构
[1] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, NL-1098 SM Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Amsterdam, Netherlands
[3] Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands
[4] Vrije Univ Amsterdam, Ctr Med, Dept Neurosurg, Rudolf Magnus Inst Neurosci, Amsterdam, Netherlands
[5] Univ Utrecht, Med Ctr, Dept Pathol, Utrecht, Netherlands
关键词
human; rat; hippocampus; astrocytes; neurons; microglia; epileptogenesis; microarray; PCR; immunocytochemistry;
D O I
10.1016/j.nbd.2007.01.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated the involvement of the complement cascade during epileptogenesis in a rat model of temporal lobe epilepsy (TLE), and in the chronic epileptic phase in both experimental as well as human TLE. Previous rat gene expression analysis using microarrays indicated prominent activation of the classical complement pathway which peaked at 1 week after SE in CA3 and entorhinal cortex. Increased expression of C1q, C3 and C4 was confirmed in CA3 tissue using quantitative PCR at 1 day, 1 week and 3-4 months after status epilepticus (SE). Upregulation of C1q and Cad protein expression was confirmed mainly to be present in microglia and in a few hippocampal neurons. In human TLE with hippocampal sclerosis, astroglial, microglial and neuronal (5/8 cases) expression of C1q, C3c and Cad was observed particularly within regions where neuronal cell loss occurs. The membrane attack protein complex (C56-C9) was predominantly detected in activated microglial cells. The persistence of complement activation could contribute to a sustained inflammatory response and could destabilize neuronal networks involved. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:497 / 511
页数:15
相关论文
共 73 条
[1]   Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis [J].
Alexander, JJ ;
Bao, LH ;
Jacob, A ;
Kraus, DM ;
Holers, VM ;
Quigg, RJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1639 (03) :169-176
[2]   THE NEUROPATHOLOGY OF TEMPORAL-LOBE EPILEPSY [J].
ARMSTRONG, DD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (05) :433-443
[3]  
Aronica E, 2001, ACTA NEUROPATHOL, V101, P383
[4]   Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy [J].
Aronica, E ;
Gorter, JA ;
Redeker, S ;
Ramkema, M ;
Spliet, WGM ;
van Rijen, PC ;
Leenstra, S ;
Troost, D .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (03) :280-291
[5]   Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in Taylor-type focal cortical dysplasia [J].
Aronica, E ;
Gorter, JA ;
Jansen, GH ;
van Veelen, CWM ;
van Rijen, PC ;
Ramkema, M ;
Troost, D .
EPILEPSIA, 2003, 44 (06) :785-795
[6]   Cystatin C, a cysteine protease inhibitor, is persistently up-regulated in neurons and glia in a rat model for mesial temporal lobe epilepsy [J].
Aronica, E ;
van Vliet, EA ;
Hendriksen, E ;
Troost, D ;
da Silva, FHL ;
Gorter, JA .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 14 (09) :1485-1491
[7]   Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy [J].
Aronica, E ;
van Vliet, EA ;
Mayboroda, OA ;
Troost, D ;
da Silva, FHL ;
Gorter, JA .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (07) :2333-2344
[8]   DIFFERENTIAL REGULATION OF C3 GENE-EXPRESSION IN HUMAN ASTROGLIOMA CELLS BY INTERFERON-GAMMA AND INTERLEUKIN-1-BETA [J].
BARNUM, SR ;
JONES, JL .
NEUROSCIENCE LETTERS, 1995, 197 (02) :121-124
[9]   HUMORAL AND CELLULAR IMMUNE PARAMETERS IN UNTREATED AND PHENYTOIN-TREATED OR CARBAMAZEPINE-TREATED EPILEPTIC PATIENTS [J].
BASARAN, N ;
HINCAL, F ;
KANSU, E ;
CIGER, A .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (12) :1071-1077
[10]   Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas [J].
Becker, AJ ;
Klein, H ;
Baden, T ;
Aigner, L ;
Normann, S ;
Elger, CE ;
Schramm, J ;
Wiestler, OD ;
Blümcke, I .
ACTA NEUROPATHOLOGICA, 2002, 104 (04) :403-408